Pacs Group, INC 8-K filings

PACS Group, Inc. announced the results of its 2026 Annual Meeting of Stockholders, including the election of two directors and the ratification of its independent auditor.

PACS Group, Inc. announced robust first quarter 2026 financial results, exceeding expectations with significant increases in revenue and net income, leading to an upward revision of full-year Adjusted EBITDA guidance.

PACS Group, Inc. has appointed Carey P. Hendrickson as Chief Financial Officer, succeeding co-founder Mark Hancock, who will transition to Vice Chairman of the Board.

PACS Group, Inc. announced the appointment of Dr. Patrick H. Conway, former CMS Deputy Administrator and current CEO of Optum, to its Board of Directors, effective immediately.

PACS Group, a leading post-acute healthcare company, announced robust financial results for fiscal year and fourth quarter 2025, alongside optimistic 2026 guidance.

PACS Group, Inc. announced the results of its 2025 Annual Meeting, where stockholders elected two Class I directors and approved all proposals, including auditor ratification and executive compensation.

PACS Group, Inc. and its subsidiary PACS Holdings, LLC, obtained waivers for numerous defaults under their Credit Agreement and Master Lease, averting immediate financial distress.

PACS Group, Inc. announced robust third-quarter 2025 financial results, including a 31% revenue increase, and confirmed the completion of its financial statement restatement and Audit Committee investigation.

PACS Group, Inc. announced extensions to its forbearance agreements with lenders and landlords while continuing efforts to meet a November 19, 2025 NYSE reporting deadline.

PACS Group, Inc. received a NYSE listing extension until November 19, 2025, to complete financial restatements, while announcing preliminary record revenue and Adjusted EBITDA for the first half of 2025.

PACS Group, Inc. received an extension from the NYSE until November 19, 2025, to file delinquent reports and restate prior financial statements, which are no longer reliable, due to an ongoing audit committee investigation.

PACS Group's Chief Financial Officer, Derick Apt, resigned following an investigation into policy violations, with co-founder Mark Hancock appointed as interim CFO.

PACS Group, Inc. entered a forbearance agreement with lenders and landlords due to multiple events of default, while its President, Peter Sanford, resigned.

PACS Group, Inc. has determined that its financial statements for Q1 and Q2 2024 should no longer be relied upon due to an overstatement of revenue related to Medicare Part B billing, leading to delayed subsequent filings and an NYSE compliance extension.

PACS Group, Inc. has amended its credit agreement to extend financial statement delivery deadlines and received an extension from the NYSE to regain compliance, as the company continues to delay multiple SEC filings due to an ongoing independent audit investigation.

PACS Group, Inc. secures an amendment to its credit agreement, extending the deadline for delivering audited financial statements for the fiscal year ended December 31, 2024.

PACS Group has received a notice from the NYSE for failing to file its quarterly report on time, triggering a six-month period to regain compliance.

PACS Group has amended its credit agreement with Truist Bank and other lenders, extending the deadline for delivering its Q3 2024 unaudited financial statements.

PACS Group has delayed its third-quarter earnings release and conference call due to an ongoing investigation, while also reporting strong preliminary operational metrics for the quarter ended September 30, 2024.

PACS Group announced a 29% year-over-year revenue increase for Q2 2024, but also reported a net loss due to a significant rise in stock-based compensation expenses.

PACS Group has announced changes to the composition of its board committees, effective immediately on June 19, 2024.

PACS Group announced a robust first quarter of 2024, with significant increases in revenue, net income, and adjusted EBITDA compared to the same period last year.

PACS Group, Inc. completes key agreements and structural changes in connection with its initial public offering, including registration rights and stockholder agreements, and amendments to its certificate of incorporation and bylaws.